Cyclopharm Ltd (ASX: CYC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cyclopharm Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$154.07 million
P/E Ratio
N/A
Dividend Yield
0.60%
Shares Outstanding
93.37 million
Earnings per share
-0.079
Dividend per share
0.01
Year To Date Return
-33.60%
Earnings Yield
N/A
Franking
N/A
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cyclopharm Ltd (ASX: CYC)
Latest News
Share Gainers
Cyclopharm (ASX:CYC) share price jumps on trading update
Healthcare Shares
Why the Cyclopharm (ASX:CYC) share price is crashing 42% lower
Healthcare Shares
Why is the Cyclopharm (ASX:CYC) share price down today?
Share Market News
Why the Cyclopharm (ASX:CYC) share price popped 6% today
Share Market News
Why the Cyclopharma (ASX:CYC) share price surged to record high today
Speculative
Cyclopharm share price rockets 22% higher on FDA application approval
Investing
3 speculative micro-cap shares that could make you a fortune
Investing
3 cheap diversified micro-cap stocks for your portfolio
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 01 Apr 2021 | $0.0050 | 0.00% | Final | 13 Apr 2021 |
| 04 Sep 2020 | $0.0050 | 0.00% | Interim | 14 Sep 2020 |
| 30 Mar 2020 | $0.0050 | 0.00% | Final | 07 Apr 2020 |
| 06 Sep 2019 | $0.0050 | 0.00% | Interim | 16 Sep 2019 |
| 05 Apr 2019 | $0.0050 | 0.00% | Final | 15 Apr 2019 |
| 07 Sep 2018 | $0.0050 | 0.00% | Interim | 17 Sep 2018 |
| 06 Apr 2018 | $0.0050 | 0.00% | Final | 16 Apr 2018 |
| 01 Sep 2017 | $0.0050 | 0.00% | Interim | 11 Sep 2017 |
| 31 Mar 2017 | $0.0050 | 0.00% | Final | 10 Apr 2017 |
| 02 Sep 2016 | $0.0050 | 46.00% | Interim | 12 Sep 2016 |
| 11 Apr 2016 | $0.0050 | 100.00% | Interim | 19 Apr 2016 |
| 05 Oct 2015 | $0.0050 | 100.00% | 14 Oct 2015 |
CYC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cyclopharm Ltd
Cyclopharm Ltd is a company that engages in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development. It operates through the following segments. The Technegas segment involves supplying diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. The Molecular Imaging segment offers to produce radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders, and cardiac disease. The firm generates maximum revenue from the Technegas segment.
CYC Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 04 Aug 2021 | $1.65 | $0.01 | 0.61% | 96,529 | $1.64 | $1.65 | $1.60 |
| 03 Aug 2021 | $1.64 | $-0.02 | -1.21% | 26,200 | $1.63 | $1.64 | $1.63 |
| 02 Aug 2021 | $1.66 | $0.00 | 0.00% | 38,458 | $1.66 | $1.66 | $1.65 |
| 30 Jul 2021 | $1.66 | $-0.04 | -2.36% | 31,923 | $1.68 | $1.70 | $1.64 |
| 29 Jul 2021 | $1.70 | $0.00 | 0.00% | 15,592 | $1.70 | $1.70 | $1.68 |
| 28 Jul 2021 | $1.70 | $0.03 | 1.80% | 8,207 | $1.67 | $1.70 | $1.64 |
| 27 Jul 2021 | $1.67 | $0.02 | 1.21% | 25,142 | $1.65 | $1.67 | $1.63 |
| 26 Jul 2021 | $1.65 | $-0.06 | -3.52% | 53,220 | $1.67 | $1.70 | $1.65 |
| 23 Jul 2021 | $1.71 | $0.05 | 3.01% | 33,980 | $1.67 | $1.71 | $1.67 |
| 22 Jul 2021 | $1.66 | $-0.01 | -0.60% | 26,086 | $1.66 | $1.67 | $1.66 |
| 21 Jul 2021 | $1.67 | $0.04 | 2.45% | 100,061 | $1.68 | $1.70 | $1.66 |
| 20 Jul 2021 | $1.63 | $-0.05 | -2.98% | 32,814 | $1.64 | $1.68 | $1.63 |
| 19 Jul 2021 | $1.68 | $0.05 | 3.08% | 24,750 | $1.65 | $1.70 | $1.63 |
| 16 Jul 2021 | $1.63 | $-0.05 | -2.98% | 52,418 | $1.68 | $1.68 | $1.63 |
| 15 Jul 2021 | $1.68 | $0.01 | 0.60% | 5,863 | $1.66 | $1.70 | $1.66 |
| 14 Jul 2021 | $1.67 | $0.01 | 0.60% | 14,548 | $1.70 | $1.70 | $1.67 |
| 13 Jul 2021 | $1.66 | $0.00 | 0.00% | 24,004 | $1.66 | $1.70 | $1.66 |
| 12 Jul 2021 | $1.66 | $0.00 | 0.00% | 45,563 | $1.66 | $1.72 | $1.66 |
| 09 Jul 2021 | $1.66 | $0.01 | 0.61% | 22,161 | $1.65 | $1.66 | $1.64 |
| 08 Jul 2021 | $1.65 | $0.01 | 0.61% | 14,418 | $1.64 | $1.65 | $1.62 |
| 07 Jul 2021 | $1.64 | $-0.04 | -2.38% | 44,408 | $1.67 | $1.67 | $1.62 |
| 06 Jul 2021 | $1.68 | $-0.05 | -2.89% | 21,223 | $1.70 | $1.73 | $1.65 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 05 Mar 2021 | David Heaney | Buy | 3 | $8,045 |
On-market trade.
|
| 26 Feb 2021 | Thomas (Tom) McDonald | Buy | 2 | $6,262 |
On-market trade.
|
| 19 Feb 2021 | Thomas (Tom) McDonald | Issued | 12 | $31,238 |
Participation in share purchase plan.
|
| 19 Feb 2021 | David Heaney | Issued | 9 | $24,102 |
Participation in share purchase plan.
|
| 19 Oct 2020 | Thomas (Tom) McDonald | Buy | 1 | $2,260 |
On-market trade.
|
| 29 Sep 2020 | Thomas (Tom) McDonald | Buy | 4 | $10,042 |
On-market trade.
|
| 29 Sep 2020 | Thomas (Tom) McDonald | Buy | 29 | $65 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr David James Heaney | Non-Executive DirectorNon-Executive Chairman | Nov 2006 |
Mr Heaney has more than 40 years experience in all aspects of wholesale banking and finance, gained in senior management roles with National Australia Bank Limited and subsidiary companies in both Australia and the US. He served as a non-executive director of Colorpak Limited from February 2004 until May 2016 and has also previously been a non-executive director of other listed and non-listed companies.
|
| Mr Thomas (Tom) Arthur McDonald | Non-Executive Director | Apr 2017 |
Mr McDonald has more than 30 years experience in the technology and pharmaceutical industries and has held global senior executive roles with international biotech Beckman Instruments Inc, with roles based in USA and Asia Pacific. He Chairs the Risk Committee.
|
| Mr James S McBrayer | Chief Executive OfficerManaging DirectorCompany Secretary | Jun 2008 |
Mr McBrayer has more than 30 years experience in nuclear medicine. He held the role of Managing Director at Lipa Pharmaceuticals, Australia's contract manufacturer of over the counter products and senior management positions with Brambles Cleanaway business and Syncor, the world's radioactive diagnostic and therapeutic pharmaceutical provider.
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| National Nominees Limited | 13,556,315 | 14.52% |
| Anglo Australian Christian And Charitable Fund | 13,211,332 | 14.15% |
| Barings Acceptance Limited | 11,444,962 | 12.26% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 9,091,031 | 9.74% |
| Chemical Overseas Limited | 8,005,769 | 8.57% |
| Cvc Limited | 6,644,758 | 7.12% |
| CS Third Nominees Pty Limited | 1,722,125 | 1.84% |
| Mcbrayer Reid Investments Pty Ltd (Ltip Account Holding 6) | 1,721,554 | 1.84% |
| Citicorp Nominees Pty Limited | 1,202,550 | 1.29% |
| Chemical Overseas Limited I | 1,182,239 | 1.27% |
| Phillips River Pty Ltd | 1,038,914 | 1.11% |
| Cs Fourth Nominees Pty | 1,015,547 | 1.09% |
| Lloyds & Casanove Investment Partners Ltd | 987,503 | 1.06% |
| Mr James Mcbrayer | 861,728 | 0.92% |
| Mr James Mcbrayer I | 861,728 | 0.92% |
| South Seas Holdings Pty Limited | 686,538 | 0.74% |
| City & Westminster Limited | 556,327 | 0.60% |
| Mcbrayer Reid Investments Pty Ltd (Ltip Account Holding 8) | 500,000 | 0.54% |
| Mathew Farag (Ltip Account Holding 4) | 500,000 | 0.54% |
| Malackey Holdings Pty Ltd | 431,758 | 0.46% |